↓ Skip to main content

Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry

Overview of attention for article published in Digestive and Liver Disease, August 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#32 of 2,097)
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
1 news outlet
twitter
33 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry
Published in
Digestive and Liver Disease, August 2022
DOI 10.1016/j.dld.2022.07.013
Pubmed ID
Authors

Míriam Mañosa, Agnès Fernández-Clotet, Pilar Nos, María Dolores Martín-Arranz, Noemí Manceñido, Ana Carbajo, Esther Hinojosa, Alejandro Hernández-Camba, Roser Muñoz-Pérez, Maia Boscá-Watts, Marta Calvo, Mónica Sierra-Ausín, Eugenia Sánchez-Rodríguez, Manuel Barreiro-de Acosta, Alejandro Núñez-Alonso, Yamile Zabana, Lucía Márquez, Javier P Gisbert, Jordi Guardiola, Empar Sáinz, Pedro Delgado-Guillena, David Busquets, Manuel van Domselaar, Eva Girona, Rufo Lorente, Diego Casas-Deza, José M. Huguet, Sergio Maestro, M. José Cabello, Jesús Castro, Marisa Iborra, Fiorella Cañete, Margalida Calafat, Eugeni Domènech, ENEIDA registry by GETECCU

X Demographics

X Demographics

The data shown below were collected from the profiles of 33 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 6 21%
Student > Bachelor 3 11%
Librarian 2 7%
Student > Doctoral Student 2 7%
Student > Ph. D. Student 2 7%
Other 9 32%
Unknown 4 14%
Readers by discipline Count As %
Medicine and Dentistry 14 50%
Biochemistry, Genetics and Molecular Biology 3 11%
Computer Science 1 4%
Agricultural and Biological Sciences 1 4%
Psychology 1 4%
Other 1 4%
Unknown 7 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 March 2023.
All research outputs
#1,354,570
of 25,593,129 outputs
Outputs from Digestive and Liver Disease
#32
of 2,097 outputs
Outputs of similar age
#29,791
of 433,275 outputs
Outputs of similar age from Digestive and Liver Disease
#2
of 49 outputs
Altmetric has tracked 25,593,129 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,097 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,275 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.